These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 400714)

  • 41. Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension.
    Dluhy RG; Bavli SZ; Leung FK; Solomon HS; Moore TJ; Hollenberg NK; Williams GH
    J Clin Invest; 1979 Nov; 64(5):1270-6. PubMed ID: 500810
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma aldosterone regulation in anephric man.
    Walker WG; Cooke CR
    Kidney Int; 1973 Jan; 3(1):1-5. PubMed ID: 4348354
    [No Abstract]   [Full Text] [Related]  

  • 43. Vasodilating antihypertensive drug-induced aldosterone release--a study of endogenous angiotensin-mediated aldosterone release in the rat.
    Campbell WB; Pettinger WA; Keeton K; Brooks SN
    J Pharmacol Exp Ther; 1975 Apr; 193(1):166-75. PubMed ID: 1167223
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oxonic acid-induced hyperuricemia elevates plasma aldosterone in experimental renal insufficiency.
    Eräranta A; Kurra V; Tahvanainen AM; Vehmas TI; Kööbi P; Lakkisto P; Tikkanen I; Niemelä OJ; Mustonen JT; Pörsti IH
    J Hypertens; 2008 Aug; 26(8):1661-8. PubMed ID: 18622246
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
    Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of plasma aldosterone in anephric and non-nephrectomized patients during hemodialysis treatment.
    Olgaard K; Madsen S
    Acta Med Scand; 1977; 201(5):457-62. PubMed ID: 899867
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma aldosterone during extracellular fluid volume expansion in patients on regular haemodialysis.
    Olgaard K; Madsen S; Ladefoged J; Regeur L
    Eur J Clin Invest; 1977 Feb; 7(1):61-6. PubMed ID: 402278
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Renin gene expression in the adrenal and kidney of patients with primary aldosteronism.
    Shionoiri H; Hirawa N; Ueda S; Himeno H; Gotoh E; Noguchi K; Fukamizu A; Seo MS; Murakami K
    J Clin Endocrinol Metab; 1992 Jan; 74(1):103-7. PubMed ID: 1727806
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation of plasma aldosterone concentration in anephric man and renal transplant recipients.
    Cooke CR; Ruiz-Maza F; Kowarski A; Migeon CJ; Walker WG
    Kidney Int; 1973 Mar; 3(3):160-6. PubMed ID: 4572243
    [No Abstract]   [Full Text] [Related]  

  • 50. The role of the renin-angiotensin system in the control of aldosterone secretion.
    Slater JD
    Proc R Soc Med; 1969 Dec; 62(12):1251-3. PubMed ID: 4312096
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effect of hemodialysis on plasma aldosterone in anephric patients (author's transl)].
    Vetter W; Záruba K; Armbruster H; Beckerhoff R; Siegenthaler W
    Klin Wochenschr; 1975 Jan; 53(1):17-20. PubMed ID: 1123892
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dissociation of the diurnal variation of aldosterone and cortisol in anephric subjects.
    Cooke CR; Whelton PK; Moore MA; Caputo RA; Bledsoe T; Walker WG
    Kidney Int; 1979 Jun; 15(6):669-75. PubMed ID: 572442
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Renin-aldosterone response and systemic blood pressure in long-term anephric patients on hemodialysis.
    Avram MM
    ASAIO Trans; 1986; 32(1):379-83. PubMed ID: 3535848
    [No Abstract]   [Full Text] [Related]  

  • 54. Plasma angiotensins in anephric humans: evidence for an extrarenal angiotensin system.
    Wilkes BM; Mento PF; Pearl AR; Hollander AM; Mossey RT; Bellucci A; Bluestone PA; Mailloux LU
    J Cardiovasc Pharmacol; 1991 Mar; 17(3):419-23. PubMed ID: 1711603
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The renin-angiotensin-aldosterone system in diabetic patients with hyperkalemia.
    Sunderlin FS; Anderson GH; Streeten DH; Blumenthal SA
    Diabetes; 1981 Apr; 30(4):335-40. PubMed ID: 7009278
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term clinical spectrum and circulating RAS evaluation of anephric patients undergoing hemodialysis: A report of four cases and literature review.
    Liu L; Zhang Y; Fu F; Zhuo L; Wang Y; Li W
    J Renin Angiotensin Aldosterone Syst; 2018; 19(3):1470320318799904. PubMed ID: 30264674
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased plasma aldosterone concentration in response to hemodialysis in nephrectomized man.
    McCaa RE; McCaa CS; Read DG; Bower JD; Guyton AC
    Circ Res; 1972 Oct; 31(4):473-80. PubMed ID: 4342412
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of furosemide and orthostasis on active and inactive renin in normal and anephric man.
    Konrads A; Hummerich W; Vlaho M; Meurer KA
    Eur J Clin Invest; 1981 Apr; 11(2 Suppl 1):105-9. PubMed ID: 6785094
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of renin on extrarenal erythropoietin production.
    Anagnostou A; Baranowski R; Pillay VK; Kurtzman N; Vercellotti G; Fried W
    J Lab Clin Med; 1976 Nov; 88(5):707-15. PubMed ID: 989773
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Renin and renin inhibition in anephric man.
    Opsahl JA; Smith KL; Murray RD; Abraham PA; Katz SA
    Clin Exp Hypertens; 1993 Mar; 15(2):289-306. PubMed ID: 8467318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.